MENU
ARVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arvinas (ARVN) Earnings Date & Reports

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ARVN is expected to report earnings to rise 50.44% to -94 cents per share on May 06

Arvinas ARVN Stock Earnings Reports
Q1'25
Est.
$-0.95
Q4'24
Beat
by $0.33
Q3'24
Beat
by $0.16
Q2'24
Beat
by $0.59
Q1'24
Beat
by $0.43
The last earnings report on February 11 showed earnings per share of -62 cents, beating the estimate of -95 cents. With 2.14M shares outstanding, the current market capitalization sits at 493.78M.
View a ticker or compare two or three
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapies to degrade disease-causing proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
395 Winchester Avenue
Phone
+1 203 535-1456
Employees
445
Web
https://www.arvinas.com